Researchers in the spotlight

Researchers across the faculties at the NWU continue to produce exciting work in their fields of expertise.

We introduce the work of two researchers - Prof Muchativugwa Liberty Hove, deputy director of the School of Language in Education, and Dr Wihan Pheiffer, senior lecturer at the DSI/NWU Preclinical Drug Development Platform (PCDDP…

NWU rakes in eight nominations for ‘Science Oscars’

The North-West University (NWU) has received eight nominations for this year’s prestigious NSTF-South32 Awards. It is another feather in the University’s cap in its pursuit of excellence without boundaries.

The NSTF-South 32 Awards, also known as the ‘Science Oscars’, is the largest, most comprehensive and one of the most coveted…

Academic to lead preclinical GLP toxicity hub for pharmaceuticals development

South Africa and the North-West University (NWU) are stepping up to develop the African continent’s capabilities to develop its own human vaccines.

The glaring disparities in vaccine access during the Covid-19 pandemic has led to South Africa taking significant strides to bridge the gap between the global north and the African continent…

Staff member and student impress at pharmaceutical conference

North-West University (NWU) academic Prof Lesetja Legoabe and student Monique Labuschagne had an impressive showing at the 42nd Academy of Pharmaceutical Science of South Africa (APSSA) Conference.

Prof Legoabe from the Centre of Excellence for Pharmaceutical Sciences received the best publication award for his work titled "…

Academic shines bright at Oxford innovation boot camp

Prof Rose Hayeshi, associate professor at the North-West University’s (NWU’s) DSI/NWU Preclinical Drug Development Platform has just returned from the United Kingdom after a week-long innovation boot camp at the University of Oxford.

Prof Hayeshi was one of the 10 participants selected to deliver demo pitches, after which her…

Preclinical research: the bridge to new medicines

“Preclinical research serves as a bridge to new medicines,’’ says North-West University (NWU) academic Prof Rose Hayeshi, associate professor and director of the DSI/NWU Preclinical Drug Development Platform (PCDDP).

Preclinical drug development is one of the stages of development for new medicines and her specific interest is in drug…

Top scientists unite to launch Pan-African Disease Foundation

A consortium of African universities and research institutions led by the Walter Sisulu University from South Africa, today announced the founding of the Sisulu Foundation for African and Pandemic Disease Response ("The Sisulu Foundation").

The Foundation will…

University collaboration reaches promising Covid-19 vaccine results

Walter Sisulu University (WSU) and the North-West University (NWU) jointly announced "very promising first results" from preclinical trials on a new Covid-19 vaccine candidate on Tuesday, 8 June. 

The WSU Medical School has a rich history of producing quality medical doctors and nurses for the South African and international health…

Rose Hayeshi – a rising star at the BioAfrica Convention

A researcher from the North-West University (NWU) and one of the rising stars in science, technology, engineering and mathematics (STEM), is taking part in this year’s BioAfrica Convention that is taking place from 24 to 26 August.

Prof Rose Hayeshi, director of and associate professor at the DSI/NWU Preclinical Drug Development…

NWU to validate new Covid-19 test

As the Covid-19 pandemic continues to wreak havoc locally and internationally, NWU’s experts have been roped in to assist with the validation of a new test in the fight against it.

The new test is being developed by a wholly owned South African pharmaceutical company, Austell Pharmaceuticals (Pty) Ltd. It is anticipated that this…